Avastin
bevacizumab · VEGF / Angiogenesis Inhibitor
Indications & Uses
Metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma multiforme, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Contraindications
None with approved oncology indications.
Side Effects & Warnings
Gastrointestinal perforations, surgery and wound healing complications, severe hemorrhage, arterial thromboembolic events, hypertension, and proteinuria.
Drug & Dietary Interactions
No formal drug interaction studies; increased risk of microangiopathic hemolytic anemia with sunitinib malate.
Regulatory & Prescribing Information
FDA Approved Biologic (BLA 125085). Black Box Warning for Gastrointestinal Perforation and Wound Dehiscence.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.